causes or cancer. Sclaich and colleagues 45 showed a significant decrease in pulmonary function test parameters, namely vital capacity and forced expiratory volume in 1 second, in patients with VCFs who were compared with an age-matched control group with chronic low-back pain. Thus, the clinical consequences of VCF include loss of height and exaggerated thoracic kyphosis with lumbar lordosis, with associated pulmonary difficulties. 47 Loss of mobility and decreased exercise tolerance are common, with associated chronic depression that may worsen the chronic back pain associated with the deformity.
When treating patients with osteoporosis, several caveats concerning procedures are important. This is a systemic disease requiring systemic treatment. For most interventional specialists this is beyond the scope of their practice, and patients are treated by their primary care physician or an endocrinologist. Calcium supplements, vitamin D, hormone replacement therapy, selective estrogen replacement modulators, bisphosphonates, and intranasal calcitonin are pharmacological treatments that are often used alone or in combination for this condition. 24 The importance of weight-bearing exercise and fall precautions should always be emphasized.
Patient Selection
Ideal candidates for PV or PK have mostly activityrelated axial pain corresponding to the level of a recent compression fracture. This pain lessens or disappears completely with recumbency and/or sitting still. Many clinicians use tenderness over the appropriate level as an indication for PV or PK, although recently Gaughen, et al., 15 analyzed a series of 90 patients undergoing PV and found 10 who had experienced no tenderness preoperatively. Subgroup analysis in that group of 10 patients revealed excellent outcomes; thus, these authors argue for a careful evaluation of the patient's history, MR imaging findings, plus possible bone scan findings, but not for making pain on palpation a necessary condition for PV. A complete neurological examination and evaluation of recent radiographic studies is mandatory. The MR image will demonstrate an increased T 2 signal due to bone edema at the level of a recent fracture. Bone scans have also been used to target the most recent break(s) in patients with multiple fractures. 31 Spinal cord compression on MR images (in the absence of neurological findings) is a relative contraindication. If on MR images there is a suspicion of a posterior cortical fracture, a computerized tomography scan will reveal more details of the bone architecture. Plain spine x-ray films may help give an idea of pedicle anatomy to aid in planning the procedure, that is, small pedicles may favor PV with a smaller needle instead of the larger trochar used with PK.
General Tenets/Contraindications
Before the procedure is performed, all anticoagulant regimens should be discontinued and the patient's coagulation profile should be normal. The platelet count should be at least 100,000 at the time of the procedure. Sepsis is a contraindication, as is active infection. We recommend waiting at least 2 weeks after treatment of an infection to minimize infectious risks.
Informed consent (see Postprocedure Complications)
should include information about the following possibilities: lack of pain relief, osteomyelitis, fracture of the vertebra or pedicle, extravasation of cement into the spinal canal or neural foramen, paralysis or nerve root damage, and venous embolism. Also, the need for open surgery should be discussed with the patient.
Technical Aspects of the Procedure
Vertebroplasty and kyphoplasty require the clinician to be trained in spinal anatomy, fluoroscopic imaging, and the use of these methods to perform interventional procedures. The procedure should be performed in a sterile operating suite that will allow fluoroscopic imaging of the thoracolumbar spine. Biplanar or C-arm fluoroscopy of good quality is mandatory for maximal procedural safety. A radiolucent table is mandatory, as is appropriate padding for prone, slightly flexed positioning. Other materials needed for the procedure include local anesthetic solution (we use a 50:50 mixture of 1% lidocaine with 0.25% bupivacaine), PMMA material, and barium or other radiopacification material. In addition, some groups have advocated tobramycin powder. Also needed are 11-or 13-gauge bone biopsy needles with connection tubing and cement injection syringes. (Many commercial kits are available; see Appendix for materials list and vendor addresses.) Induction of general anesthesia or monitored anesthesia care can be performed. If monitored anesthesia care is used, the surgeon must apply generous amounts of the local anesthetic agent, especially onto the periosteum, where much nociception occurs. Some patients experience discomfort with advancement of the trochars across the posterior cortical margin, with balloon inflation (in the case of kyphoplasty), and with PMMA injection. The anesthesiologist must be prepared to "deepen" the monitored anesthesia during these phases of the procedure. Patient selection is important when considering the anesthesia choice. Very anxious or nervous patients may have a better experience with general anesthesia. Careful consideration must be given to padding the pressure points of this physically fragile group of patients.
After uni-or bipedicular VB access has been obtained, some clinicians proceed directly with injection of PMMA, whereas others prefer to perform venography prior to cement injection. In theory, venography provides anatomical knowledge of the large venous channels in proximity to the trochar. This information is used to enable the physician to inject the PMMA with more care. For example, if injection of a small amount of contrast material reveals a direct spread into a venous channel, the operator may move the trochar before injection of the cement, or carefully inject relatively solidified PMMA to embolize the large vein before injecting more PMMA into the VB. The literature reveals inconsistent efficacy in the use of venography. 16, 32, 50 We use venography in cases in which a metastatic tumor is located near the posterior cortical margin. In cases of osteoporotic fractures, we do not routinely use this modality.
Injection of PMMA into the VB is undertaken after careful imaging confirming insertion of the trochar or trochars in the anteromedial portion of the VB (Fig. 1) . The PMMA should be opacified and beginning to harden to A. W. Burton, L. D. Rhines, and E. Mendel the consistency of toothpaste prior to injection. The procedure can be performed using small syringes filled with PMMA or one of several commercially available kits. The injection must be done with the aid of live lateral or biplanar fluoroscopic guidance. If the PMMA begins to go into a blood vessel or toward the posterior cortical margin, the injection must be halted immediately. We halt cement injection when it spreads to the posterior one-third of the VB (Fig. 2) . To minimize PMMA leakage, Fourney and colleagues 12 recommend the use of high-viscosity cement, kyphoplasty in selected cases, and a relatively small-volume injection (Fig. 3) .
OUTCOMES
There have been many outcome studies, both retrospective reviews and prospective case series ( Table 1) . Many of these studies are of a very high quality and are reviewed in this article. To our knowledge, no randomized controlled trials of PV compared with conservative treatment have been done. With such good clinical outcomes for PV and PK, such a trial may be difficult to conduct because patients and clinicians would be unenthusiastic about being randomized to the conservative treatment arm. There also are no controlled trials comparing PV and PK, although numerous authors have published descriptive comparative analyses, as we discuss in the following sections.
Effectiveness of PV in Osteoporotic VCFs
Zoarski and colleagues 55 performed a prospective analysis of 30 patients undergoing PV for osteoporotic VCFs at 54 levels, with follow-up periods as long as 18 months. Their patients' mean age was 79 years and they were predominately female. The patients were evaluated with an instrument called the Musculoskeletal Outcomes Data Evaluation and Management Scale. Significant improvement was noted in pain and disability levels, physical function, and mental function. These improvements were seen by 2 weeks and continued up to the 18-month follow-up visit. One patient suffered an asymptomatic epidural PMMA leak.
McGraw, et al., 33 prospectively evaluated 100 patients undergoing PV for osteoporotic VCFs. These individuals underwent PV at 156 levels (68 thoracic and 88 lumbar) over a 35-month period. In this group, 97% of patients reported significant pain relief at 24 hours that was sustained for a mean follow-up duration of 21 months. The pain scores dropped from 8.9 to 2.0 postprocedure, and 93% of patients noted an increased activity level. There were two complications, a sternal fracture and a transient radiculopathy.
Cortet, et al., 9 prospectively evaluated 16 patients undergoing PV for osteoporotic VCFs; in these patients the procedure was performed at 20 levels. Pain scores assigned based on the VAS and McGill criteria significantly improved (by a mean of 56% by Day 3), and this was sustained as late as Day 180. The Nottingham Health Profile improved significantly in the dimensions of pain, physical mobility, emotional reactions, social isolation, and energy. There were no complications and no further VCFs, and the improvements were sustained as late as the 6-month follow-up visit.
Perez-Higueras and colleagues 40 prospectively assessed clinical and radiographic outcomes in 12 patients over a 5-year period. Initial pain scores were 9.1/10, falling to 2.1/10 on the 3rd day postprocedure, and they remained at 2.2/10 at 5 years. The McGill pain questionnaire showed a significant improvement after treatment, but the outcomes had worsened by the 5-year follow-up visit. All patients were "very satisfied" or "somewhat satisfied" with the procedure. Three patients suffered four new fractures over the 5-year follow-up period, two of which were adjacent to treated levels. Postprocedure computerized tomography scans revealed cement in the epidural veins in 48% of cases, but only one patient had a transient neuritis.
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Vertebroplasty and kyphoplasty: a comprehensive review Grados, et al., 17 provided insight into the long-term outcomes with a long-term retrospective follow-up analysis. In their series, PV was performed for osteoporotic VCFs in 40 patients between 1990 and 1996. In 1997, the patients were asked to return for reevaluation; the mean duration of follow-up was 48 months after PV. Pain scores decreased from 8.0/10 preprocedure to 3.7/10 at the 1-month follow up and 3.4/10 at maximal follow up. There were no complications, but these authors found a slightly increased risk of VCF in vertebrae adjacent to the treated level. The odds ratio of a fracture near a treated level was 2.27, compared with 1.44 in a location remote from the treated level. The significance of this is unclear. These authors concluded that PV is a safe and effective procedure for treatment of focal back pain caused by osteoporotic VCF.
Barr and colleagues 2 performed a retrospective review in 47 consecutive patients who were treated over 3 years with PV at 84 vertebral levels. Osteoporotic VCFs were present in 38 of the patients, eight had primary or metastatic tumor-related VCFs, and one had a hemangioma. Among the 38 patients with osteoporosis, 63% attained marked pain relief, 32% experienced moderate pain relief, and in 5% there was no significant change. In the group with tumor-related VCF, only 50% had significant pain relief, and the patient with the hemangioma experienced no relief. Three patients had minor complications.
Mckiernan, et al., 34 reported a prospective analysis of pain scores and QOL in 46 consecutive patients undergoing PV for 66 osteoporotic fractures. They found an improvement in pain scores from 7.7 preoperatively to 2.8 at the 2-week follow-up visit, which was sustained until the 6-month follow-up review (p Ͻ 0.001). They also noted significant improvement in scores on the osteoporosis QOL questionnaire. The PMMA extravasation rate was 15% and none of the leaks caused symptoms.
Alvarez, et al., 1 performed an extensive retrospective review of outcomes after PV, in an effort to define predictors of good outcomes in patients treated with this procedure. These investigators reviewed 278 patients treated with PV for 423 fractured levels between 1994 and 2002. Multivariate analysis showed a correlation of the best outcomes with the following factors: two or fewer VCFs; physical status I according to the American Society of Anesthesiologists criteria (healthy); signal change on MR imaging (recent fracture); and collapse of less than 70% of VB height.
Effectiveness of PK in Osteoporotic VCFs
Lieberman, et al., 28 conducted a prospective openlabel Phase I trial of PK for this disorder, in which 30 patients underwent 70 levels of PK for painful osteoporotic VCFs. The SF-36 scores showed significant change in the measures for bodily pain and physical function postprocedure. In 70% of patients, restoration of a mean of 47% of lost VB height occurred. There was an 8.6% rate of asymptomatic PMMA leakage.
Ledlie and Renfro 26 reviewed a large retrospective series of 96 patients who had undergone PK at 133 levels, mainly for osteoporotic VCFs. The mean patient age was 76 years, and 70% were female. The mean preprocedure pain score was 8.6/10, the score was 2.7/10 in the early postprocedure period, and it was 1.4/10 at the 1-year follow-up mark. Activity levels improved dramatically in most patients. With PK, VB height is often restored, and in this cohort the mean anterior VB height changed from 65% of normal before the procedure to 90% of normal at 1 month after PMMA injection.
Outcomes in Cancer
Fourney and colleagues 12 published a retrospective re-A. W. Burton, L. D. Rhines, and E. Mendel view of 56 patients who had undergone 65 PV and/or 32 PK procedures for cancer-associated VCFs. Twenty-one patients had myeloma, whereas 35 had other primary and metastatic neoplasms. The mean age of the patients in the series was 62 years, and the mean duration of symptoms was 3.2 months. In 84% of patients, marked or complete pain relief was reported postprocedure, with a mean follow-up duration of 4.5 months. No treatment-related complications were seen. Asymptomatic PMMA leakage was noted in 9.2% of 65 levels treated with PV, whereas there was no cement leakage in the PK group. These authors presented an algorithm for choosing PV, PK, open surgery, or radiotherapy in cancer patients. Dudeney, et al., 10 prospectively evaluated a series of patients with multiple myeloma undergoing PK for painful VCFs. In this study, 18 patients underwent 55 PK procedures due to multiple myeloma. The SF-36 scores showed postprocedure improvement for the bodily pain, physical function, vitality, and social functioning scales. On average, 34% of lost vertebral height was restored. No major complications were seen, and asymptomatic PMMA leakage was observed in only 4% of treated levels.
At our institution, Wang and colleagues 52 reported our experience with myeloma patients in an Abstract. A retrospective analysis of 32 patients who underwent 43 PV and 24 PK procedures was conducted. In this series, 91% of patients reported marked or complete pain relief postprocedure. The mean preprocedure pain score was 7/10 and the mean postoperative pain score was 2/10, which continued up to the 12-month follow-up period. No major complications were seen, but asymptomatic PMMA extravasation was noted in 4% of the patients who underwent PV.
Our group has reported the value of this procedure in selected patients, even those in the very end stages of advanced metastatic disease. 4 
Outcomes in Special Circumstances
As experience grows with these techniques, various groups are pushing the envelope on indications for the procedures. There are some preliminary data/case series on the efficacy of PV and PK in patients with radicular pain, traumatic burst fractures, severe VCF/vertebra plana, cervical spine disorders, and intraoperative PMMA augmentation after pedicle screw fixation for spinal stabilization (Fig. 4) . 7, 18, 37, 39, 44, 54 
Adjacent-Level Fractures
Cortet, et al., 9 first noted a small increase in adjacentlevel fractures on long-term follow-up evaluations conducted after PV was performed. Recently, a large database of 106 patients who had undergone 212 PV procedures was evaluated over a long-term follow-up period by Kim, et al., 25 who noted 72 new fractures (7.9%) over a 3-year follow-up duration. The 1-year fracture-free rate in their series was 93% according to Kaplan-Meier analysis. The mean fracture-free interval was 32 months, with adjacent fractures being predicted based on location in the thoracolumbar junction and greater height restoration. In a much smaller study (38 patients), Lin and colleagues 29 noted a correlation between adjacent-level fracture and presence of PMMA in the adjacent disc.
COMPLICATIONS
Complications are rare, but they can be serious, and their exact incidence is unknown. The PMMA can flow out of the VB posteriorly into the spinal canal or neural foramina, or anteriorly into the paraspinous veins, with systemic consequences. There are several reports in the literature of osteomyelitis requiring corpectomy. 51 There are case reports of nerve root and spinal cord compression from extravertebral PMMA. 27, 42 Several reports of minimally symptomatic pulmonary emboli, one case of cardiovascular collapse requiring pulmonary embolectomy, one lethal pulmonary embolus, and one case of paradoxical cerebral arterial PMMA emboli have been reported. 6, 19, 46, 48 There is a suggestion in the literature that less PMMA leakage occurs with PK than with PV. 41 Complications have been reported for both procedures; a review of Food and Drug Administration safety data revealed 58 reported complications from 1999 through 2003 of approximately 200,000 procedures performed. These were approximately evenly divided between PV and PK, with more cases of pedicle fracture and spinal cord compres-
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Vertebroplasty and kyphoplasty: a comprehensive review sion from PK than from PV. 38 As further studies are completed a more accurate risk/benefit ratio can be defined.
Comparison of PV With PK
No studies have been conducted in which PV was compared with PK in a head-to-head fashion. There tend to be groups of clinicians who favor one or the other technique. Both procedures have yielded favorable outcomes with low complication rates. Although PK is 10 to 20 times more expensive than PV, it restores height in kyphotic VCFs in many patients who undergo this procedure. A recent report by an expert group of authors calls for comparative trials to be conducted to escape the current jargon and marketing claims for each procedure over the other, while noting the difficulties in conducting such trials. 30, 36 
CONCLUSIONS
These procedures, PV and PK, are newer minimally invasive techniques used to treat painful VCFs. There is a A. W. Burton, L. D. Rhines, and E. Mendel growing body of evidence, albeit of limited quality (predominately open case series), which indicates that these procedures are efficacious in alleviating the pain associated with VCF. The results of the procedures in these numerous reports are uniformly good. There are, however, a growing number of case reports of serious complications. Recent reviews and editorials have called for a more critical evaluation of PV and PK. Watts, et al., 53 reviewed the literature, concluding that controlled multicenter trials are needed to determine the short and long-term safety of these treatments. Garfin and colleagues 14 concluded that there is a 95% improvement in pain and a significant improvement in function following these procedures. They emphasized that the procedure is technically demanding and holds the potential for significant complications. They recommended further efficacy and safety studies. Jarvik and Deyo 20 called for randomized controlled trials or some type of control cohort with which to compare long-term outcomes carefully. Einhorn 11 cited the need for careful monitoring of outcomes and minimal training standards. Birkmeyer 3 recommended randomized clinical trials, citing insufficient evidence in case series to prove safety, efficacy, and cost effectiveness.
It will be difficult to conduct the randomized controlled trials needed to compare short-and long-term outcomes of PV and/or PK with those of more conservative therapies. These procedures have gained such widespread popularity that patients would undoubtedly resist being randomized to the conservative treatment group, and recent attempts at randomized controlled trials for PV have been plagued by low enrollment. Blinding would be impossible, because pain relief is usually dramatic and prompt. Other studies need to be initiated to compare PV and PK used in various disease states in a randomized fashion. Preliminary studies are underway to evaluate biological materials for spinal injection in preference to acrylic agents such as PMMA. Despite the need for more research, PV and PK have shown great promise in the treatment of painful VCFs caused by a variety of different pathological states.
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